INTRODUCTION Dr. Ahmed Farrag is a hematology and internal medicine specialist at the Thalassemia Centre at Latifa Women and Children...
Genetherapy
Today represents a key milestone for beta-thalassemia patients battling hereditary chronic disease. This comes after the approval that was granted...
The Food and Drug Administration (FDA) has given bluebird bio the green light to resume its clinical trials of gene therapy, LentiGlobin....
